The University of California Drug Discovery Consortium (UC DDC) is a cross-campus initiative aimed at building a drug discovery community that actively promotes research translation through industry partnerships.
The UC DDC was created by the University of California Biomedical Research Acceleration, Integration & Development (UC BRAID) Drugs, Devices, Diagnostics, Development (D4) group, and it has since expanded to actively include industry sponsors. Support for the consortium has been provided by a UC Office of the President (UCOP) Multi-Campus Research Proposal Initiative (MRPI) grant and its industry sponsor(s).
At this Special Webinar, UC San Diego campus lead Dr. Michael Gilson will discuss the Consortium’s core mission to provide funding and mentorship for UC researchers to advance the creation of drugs that address important unmet medical needs, and discuss its priorities to build partnerships with industry members. Industry sponsors have an opportunity to co-develop early-stage projects with UC researchers and gain early access to licensing.
Following the overview of UC DDC, the UCLA, UC Riverside and UC Berkeley campus leads will discuss their recent work to showcase the drug discovery research activities under way and answer questions from the audience.
*Language:English (English-Japanese simultaneous interpretation available)
*English captions are available (you can choose to turn them on or off).
*Please note that LINK-J and UC San Diego are not responsible for any errors or omissions in the captions.
How to use captions: Managing and viewing closed captioning
Date: Thu, June 10, 9:00-10:25am (JST) / Wed, June 9, 5:00-6:25pm (PDT)
Online (Zoom Webinar)
(Opens an external site)
Registration Fee
Free
Click ”Registration” to open an external site, and click “GET TICKET” on the right bar to sign up for the webinar.
How to participate
This event will be broadcasted on Zoom webinar. Please make a registration through Peatix.
You can join the webinar from "Watch" in the Peatix page on the webinar day.
Program
| JST | PDT | Agenda |
| 9:00-9:05am | 5:00-5:05pm | Welcome - Akihiko Soyama, LINK-J and Miwako Waga, UC San Diego |
| 9:05-9:20 | 5:05-5:20 | Presentation - “Overview of UC DDC” Michael Gilson, MD, PhD, Professor and Chair in Computer-Aided Drug Design, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego and co-director of UC San Diego’s Center for Drug Discovery Innovation |
| 9:20-9:25 | 5:20-5:25 | Q&A - moderated by Miwako Waga |
| 9:25-10:20 | 5:25-6:20 | Campus Research Overviews - moderated by Michael Gilson |
| 9:25-9:40 | 5:25-5:40 | Presentation - "Building a Drug Discovery and Development Pipeline at UCLA" Robert Damoiseaux, PhD, Professor in the Department of Molecular and Medical Pharmacology, UCLA |
| 9:40-9:55 | 5:40-5:55 | Presentation - "Targeting Therapeutically Viable Protein-Protein Interactions: Applications in Neurodegeneration and Oncology" Maurizio Pellecchia, PhD, Professor of Biomedical Sciences at the School of Medicine of the University of California Riverside (UCR) |
| 9:55-10:10 | 5:55-6:10 | Presentation - "Discovery of approved drugs synergistic with remdesivir for COVID-19" Julia Schaletzky, PhD, Founder of the UCB Drug Discovery Center, the Executive Director of the Center for Emerging and Neglected Diseases, as well as of the Immunotherapy and Vaccine Research Initiative at UC Berkeley |
| 10:10-10:20 | 6:10-6:20 | Q&A and Discussion |
| 10:20-10:25 | 6:20-6:25 | Closing Remarks - A. Soyama and M. Waga |
Biography
Michael Gilson, MD, PhD, Professor and Chair in Computer-Aided Drug Design, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego and co-director of UC San Diego’s Center for Drug Discovery Innovation
Dr Gilson’s lab focuses on theory, methods, and applications of computer-aided drug design. He has contributed to the development of a number of technologies in this area, including the creation and maintenance of BindingDB, the first publicly accessible database of protein-small molecule binding data. Dr. Gilson is currently on the faculty of UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences, and co-director of UC San Diego’s Center for Drug Discovery Innovation.
Robert Damoiseaux, PhD, Professor in the Department of Molecular and Medical Pharmacology, UCLA
Dr. Robert Damoiseaux’s main interests are in Drug Discovery and Development. He has extensively published on the development of novel assay technology platforms, High Throughput Screening, High Content Screening and nanotechnology. He is the Director of the Molecular Shared Screening Resources (MSSR) at the California NanoSystems Institute of UCLA and Professor in the Department of Molecular and Medical Pharmacology and is inventor on numerous patents.
Maurizio Pellecchia, PhD, Professor of Biomedical Sciences at the School of Medicine of the University of California Riverside (UCR)
Dr. Pellecchia is a Professor of Biomedical Sciences at the School of Medicine of the University of California Riverside (UCR) and is the founding Director of the Center for Molecular and Translational Medicine at UCR. His research laboratory focuses on the design of novel pharmacological tools and therapeutics in oncology, neurodegeneration, and other disease areas.
Julia Schaletzky, PhD, Founder of the UCB Drug Discovery Center, the Executive Director of the Center for Emerging and Neglected Diseases, as well as of the Immunotherapy and Vaccine Research Initiative at UC Berkeley
Dr. Julia Schaletzky is the Founder of the UCB Drug Discovery Center, the Executive Director of the Center for Emerging and Neglected Diseases, as well as of the Immunotherapy and Vaccine Research Initiative at UC Berkeley. An expert in drug discovery and preclinical development, Dr. Schaletzky has more than 10 years industry experience, contributing to the development of first-in-class therapies for heart failure and neurodegenerative diseases.
Participation Fee
無料（要事前登録）
Organizer
Host:LINK-J, Co-Host:UC San Diego
Contact
Email：contact@link-j.org
